BACKGROUND: 20-Hydroxyeicosatetraenoic acid (20-HETE), a metabolite of arachidonic acid (AA) produced by the CYP4A and CYP4F enzyme families has been reported to induce mitogenic and angiogenic responses both in vitro and in vivo, and inhibitors of this pathway reduced growth of brain and kidney tumors. MATERIALS AND METHODS: Real-Time PCR, western blot and immunohistochemistry were used to compare the expression of CYP4A/F mRNA and protein levels in human cancer tissue samples versus normal controls. Liquid chromatography/mass spectrometry analysis (LC-MS/MS) was performed to measure 20-HETE formation in tumor homogenates. Activation of Ras in human proximal tubule epithelial cells (HRPTEC) treated with stable agonist of 20-HETE was measured using a Ras pull-down detection kit. RESULTS: The expression of CYP4A/4F genes was markedly elevated in thyroid, breast, colon, and ovarian cancer samples in comparison to matched normal tissues. Furthermore, the levels of the CYP4F2 protein and of 20-HETE were higher in ovarian cancer samples compared to normal control tissues. A stable 20-HETE agonist induced activation of the small-GTPase Ras in HRPTEC cells. CONCLUSION: The present finding of elevated expression of CYP4A/F enzymes in human cancer tissue suggests that 20-HETE inhibitors and antagonists may be useful in the treatment of cancer.
BACKGROUND:20-Hydroxyeicosatetraenoic acid (20-HETE), a metabolite of arachidonic acid (AA) produced by the CYP4A and CYP4F enzyme families has been reported to induce mitogenic and angiogenic responses both in vitro and in vivo, and inhibitors of this pathway reduced growth of brain and kidney tumors. MATERIALS AND METHODS: Real-Time PCR, western blot and immunohistochemistry were used to compare the expression of CYP4A/F mRNA and protein levels in humancancer tissue samples versus normal controls. Liquid chromatography/mass spectrometry analysis (LC-MS/MS) was performed to measure 20-HETE formation in tumor homogenates. Activation of Ras in human proximal tubule epithelial cells (HRPTEC) treated with stable agonist of 20-HETE was measured using a Ras pull-down detection kit. RESULTS: The expression of CYP4A/4F genes was markedly elevated in thyroid, breast, colon, and ovarian cancer samples in comparison to matched normal tissues. Furthermore, the levels of the CYP4F2 protein and of 20-HETE were higher in ovarian cancer samples compared to normal control tissues. A stable 20-HETE agonist induced activation of the small-GTPase Ras in HRPTEC cells. CONCLUSION: The present finding of elevated expression of CYP4A/F enzymes in humancancer tissue suggests that 20-HETE inhibitors and antagonists may be useful in the treatment of cancer.
Authors: N Miyata; K Taniguchi; T Seki; T Ishimoto; M Sato-Watanabe; Y Yasuda; M Doi; S Kametani; Y Tomishima; T Ueki; M Sato; K Kameo Journal: Br J Pharmacol Date: 2001-06 Impact factor: 8.739
Authors: Meng Guo; Richard J Roman; John R Falck; Paul A Edwards; A Guillermo Scicli Journal: J Pharmacol Exp Ther Date: 2005-08-04 Impact factor: 4.030
Authors: Ping Chen; Meng Guo; Dana Wygle; Paul A Edwards; John R Falck; Richard J Roman; A Guillermo Scicli Journal: Am J Pathol Date: 2005-02 Impact factor: 4.307
Authors: Victor Garcia; Ankit Gilani; Brian Shkolnik; Varunkumar Pandey; Frank Fan Zhang; Rambabu Dakarapu; Shyam K Gandham; N Rami Reddy; Joan P Graves; Artiom Gruzdev; Darryl C Zeldin; Jorge H Capdevila; John R Falck; Michal Laniado Schwartzman Journal: Circ Res Date: 2017-03-21 Impact factor: 17.367
Authors: Fan Fan; Ying Ge; Wenshan Lv; Matthew R Elliott; Yoshikazu Muroya; Takashi Hirata; George W Booz; Richard J Roman Journal: Front Biosci (Landmark Ed) Date: 2016-06-01
Authors: Matthew G McDonald; Sutapa Ray; Clara J Amorosi; Katherine A Sitko; John P Kowalski; Lorela Paco; Abhinav Nath; Byron Gallis; Rheem A Totah; Maitreya J Dunham; Douglas M Fowler; Allan E Rettie Journal: Drug Metab Dispos Date: 2017-10-10 Impact factor: 3.922
Authors: Jennifer Cheng; Matthew L Edin; Samantha L Hoopes; Hong Li; J Alyce Bradbury; Joan P Graves; Laura M DeGraff; Fred B Lih; Victor Garcia; Jafar Sadik B Shaik; Kenneth B Tomer; Gordon P Flake; John R Falck; Craig R Lee; Samuel M Poloyac; Michal L Schwartzman; Darryl C Zeldin Journal: FASEB J Date: 2014-03-25 Impact factor: 5.191
Authors: Thaiz Ferraz Borin; Debora A P C Zuccari; Bruna V Jardim-Perassi; Lívia C Ferreira; A S M Iskander; Nadimpalli Ravi S Varma; Adarsh Shankar; Austin M Guo; Guillermo Scicli; Ali S Arbab Journal: PLoS One Date: 2014-12-30 Impact factor: 3.240